trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Vaccine development against COVID-19 has mitigated severe disease.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that vaccine development against COVID-19 has mitigated severe disease?

Yes. Multiple clinical guidelines and observational studies demonstrate that COVID-19 vaccination programs successfully mitigate severe disease, hospitalization, and mortality across diverse populations.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently report that COVID-19 vaccination provides substantial protection against severe disease outcomes, hospitalizations, and mortality across various populations, including vulnerable and immunocompromised groups. None of the papers refute the claim, leading to a SUPPORTED verdict.

Evidence for · 4
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19 Infections in Immunocompromised Patients.
2026
Infectious Diseases Society of America guidelines report that COVID-19 vaccination is associated with reduced hospitalization and critical illness among immunocompromised individuals.
Get citation
A, N., K, B., K, B., D, B., E, Y., Y, F., & L, B. (2026). IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19 Infections in Immunocompromised Patients.. doi.org. https://doi.org/10.1093/cid/ciag115

See more details
More for · 3
Effectiveness of coronavirus disease 2019 (COVID-19) original vaccines to prevent COVID-19-related hospitalisations among Alaska Native peoples, January 2021-October 2022.
2026
Data from American Indian/Alaska Native populations show that COVID-19 vaccines effectively prevented hospitalizations, ICU admissions, and death.
Get citation
I, B., R, S., D, B., J, G., M, F., & J, K. (2026). Effectiveness of coronavirus disease 2019 (COVID-19) original vaccines to prevent COVID-19-related hospitalisations among Alaska Native peoples, January 2021-October 2022.. doi.org. https://doi.org/10.1080/22423982.2026.2706888

Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.
2026
A multi-country European study found that adapted XBB.1.5 vaccines provided moderate to high protection against severe COVID-19 outcomes and death among immunocompromised persons.
Get citation
A, B., J, H., K, O., T, B., I, V. E., CH, H., IR, M., M, F., A, M., J, C., I, M., A, M., A, B., R, L., N, P., Y, M., N, N., S, M., & B, N. (2026). Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.. doi.org. https://doi.org/10.1080/14760584.2026.2708184

Rehospitalization due to COVID-19 reinfection in Rio de Janeiro, 2020-2022: Associations with vaccination status, sociodemographic and clinical factors.
2026
A large cohort study in Brazil demonstrated that completing a vaccination regimen with booster doses significantly reduced the risk of COVID-19-related rehospitalization.
Get citation
RKAD, N., LS, B., DA, M. V., V, S., DM, O. C., LM, C., & AG, P. (2026). Rehospitalization due to COVID-19 reinfection in Rio de Janeiro, 2020-2022: Associations with vaccination status, sociodemographic and clinical factors.. doi.org. https://doi.org/10.1371/journal.pone.0332281

What does the evidence say?

The retrieved papers consistently report that COVID-19 vaccination provides substantial protection against severe disease outcomes, hospitalizations, and mortality across various populations, including vulnerable and immunocompromised groups. None of the papers refute the claim, leading to a SUPPORTED verdict.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work